APH vs FDMT · P/E 40, rev $23.09B vs rev $37.0K
Amphenol Corporation (APH) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the APH and FDMT stock pages for the full models.
Not investment advice.